Colegio Argentino de Cardioangiólogos Intervencionistas Revista Argentina de Cardioangiología intervencionista 2250-7531 2313-9307 15 4 2024 12 30 How did I treat a peripheral AVM? 0211 0213 EN María Cecilia Masino Department of Interventional Cardiology and Endovascular Treatment (SCITE), Hospital Privado de Rosario. ORCID 0009-0005-0537-6909 cecimasino@gmail.com Martín Najenson Department of Interventional Cardiology and Endovascular Treatment (SCITE), Hospital Privado de Rosario Ignacio Cigalini Department of Interventional Cardiology and Endovascular Treatment (SCITE), Hospital Privado de Rosario Claudio Cigalini Chief of the Department of Interventional Cardiology and Endovascular Treatment (SCITE) Hospital Privado de Rosario This is the case of a male patient with a symptomatic, high-flow arteriovenous malformation (AVM) located in the right heel, with a history of previous embolizations that yielded partial results. Following a multidisciplinary discussion, the team decided on endovascular treatment using a combined technique—a transarterial approach plus direct puncture—with Onyx® (Medtronic Minneapolis, USA), an ethylene vinyl alcohol (EVOH) copolymer dissolved in dimethyl sulfoxide (DMSO) as the embolizing agent, achieving a successful outcome both in the short and long term. arteriovenous malformation, embolization, embolizing agent http://www.raci.com.ar/contenido/art.php?recordID=MjgzOA== http://recursos.meducatium.com.ar/contenido/articulos/36002110213_2838/pdf/36002110213.pdf